Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
2004 2
2005 2
2006 1
2007 3
2008 2
2009 4
2010 1
2011 4
2012 8
2013 6
2014 2
2016 1
2017 3
2018 3
2019 5
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: The SIMPLE study.
Abreu M, Tumyan A, Elhassan A, Peicher K, Papacostea O, Dimachkie P, Siddiqui MS, Pop LM, Gunasekaran U, Meneghini LF, Adams-Huet B, Li X, Lingvay I. Abreu M, et al. Among authors: meneghini lf. Diabetes Obes Metab. 2019 Sep;21(9):2133-2141. doi: 10.1111/dom.13794. Epub 2019 Jun 28. Diabetes Obes Metab. 2019. PMID: 31144435 Clinical Trial.
Role of Devices in Insulin Delivery.
Meneghini LF, McNulty JN. Meneghini LF, et al. Diabetes Technol Ther. 2017 Feb;19(2):76-78. doi: 10.1089/dia.2017.0011. Diabetes Technol Ther. 2017. PMID: 28118052 No abstract available.
Insulin therapy for type 2 diabetes.
Meneghini LF. Meneghini LF. Endocrine. 2013 Jun;43(3):529-34. doi: 10.1007/s12020-012-9817-6. Epub 2012 Oct 27. Endocrine. 2013. PMID: 23104148 Review.
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting.
Meneghini LF, Mauricio D, Orsi E, Lalic NM, Cali AMG, Westerbacka J, Stella P, Candelas Dea C, Pilorget V, Perfetti R, Khunti K; DUNE investigators. Meneghini LF, et al. Diabetes Obes Metab. 2019 Jun;21(6):1429-1436. doi: 10.1111/dom.13673. Epub 2019 Mar 28. Diabetes Obes Metab. 2019. PMID: 30768845 Free PMC article.
Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial.
Blonde L, Bailey TS, Chao J, Dex TA, Frias JP, Meneghini LF, Roberts M, Aroda VR. Blonde L, et al. Among authors: meneghini lf. Adv Ther. 2019 Sep;36(9):2310-2326. doi: 10.1007/s12325-019-01033-1. Epub 2019 Jul 29. Adv Ther. 2019. PMID: 31359368 Free PMC article.
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study.
Meneghini LF, Sullivan SD, Oster G, Busch R, Cali AMG, Dauchy A, Gill J, Bailey TS. Meneghini LF, et al. Diabetes Obes Metab. 2020 Nov;22(11):2004-2012. doi: 10.1111/dom.14152. Epub 2020 Sep 3. Diabetes Obes Metab. 2020. PMID: 32729217 Free PMC article. Clinical Trial.
46 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page